The study of the “Point of Care Infectious Disease Market ” provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Scope of the Report:
This report studies the Point Of Care Infectious Disease Market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point of Care Infectious Disease market by product type and applications/end industries.
The global Point of Care Infectious Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point of Care Infectious Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Siemens Healthineers
- Trivitron Healthcare
- Hoffmann-La Roche Ltd
- Quest Diagnostics, Inc
- BD & Company
- Chembio Diagnostics Inc
- Trinity Biotech
- Cardinal Health
- Bio-Rad Labs Inc.
- bioMérieux SA
- Thermo Fisher Scientific Inc
- Sight Diagnostics Ltd.
- Gene POC
- Ortho-Clinical Diagnostics
- OJ-Bio Ltd.
Request a sample of this report @ http://www.arcognizance.com/enquiry-sample/109567
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
Market Segment by Applications, can be divided into
- Assisted Living Healthcare Facilities
Purchase copy of this Report @ http://www.arcognizance.com/purchase/109567
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics” based on the data collection facilities of big data, the face of “business research facilities” has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the “out of the box” developments in the market.
Manager – Global Sales
Analytical Research Cognizance
+1 (646) 434-7969, +91 90967 44448